MARTEK BIOSCIENCES CORP
10-Q, EX-27, 2000-06-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MARTEK BIOSCIENCES CORP, 10-Q, EX-10, 2000-06-14
Next: MUNICIPAL INVT TR FD MON PYMT SER 526 DEFINED ASSET FDS, 485BPOS, 2000-06-14



<TABLE> <S> <C>

<ARTICLE>                     5

<S>                                                <C>
<PERIOD-TYPE>                                        6-MOS
<FISCAL-YEAR-END>                              OCT-31-2000
<PERIOD-START>                                 NOV-01-1999
<PERIOD-END>                                   APR-30-2000
<CASH>                                           3,395,018
<SECURITIES>                                    21,510,741
<RECEIVABLES>                                    2,852,489
<ALLOWANCES>                                         9,626
<INVENTORY>                                      3,974,238
<CURRENT-ASSETS>                                32,440,705
<PP&E>                                          22,263,336
<DEPRECIATION>                                   7,157,269
<TOTAL-ASSETS>                                  47,546,772
<CURRENT-LIABILITIES>                            5,133,438
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                         1,757,227
<OTHER-SE>                                      38,300,490
<TOTAL-LIABILITY-AND-EQUITY>                    47,546,772
<SALES>                                          3,213,547
<TOTAL-REVENUES>                                 4,158,688
<CGS>                                            2,501,821
<TOTAL-COSTS>                                    2,501,821
<OTHER-EXPENSES>                                 9,965,809
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                 157,324
<INCOME-PRETAX>                                (7,883,637)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                            (7,883,637)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                   (7,883,637)
<EPS-BASIC>                                          (.47)
<EPS-DILUTED>                                        (.47)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission